Vor Biopharma Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2022 Annual Meeting of Stockholders held by Vor Biopharma Inc. on June 14, 2022. The company is a Delaware corporation with its principal executive offices in Cambridge, Massachusetts, and its common stock trades on the Nasdaq Global Select Market under the symbol "VOR".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Approximately 76.69% of the shares entitled to vote were represented at the meeting, totaling 28,769,499 shares. Stockholders voted on two proposals:
- Proposal 1: Election of Three Class I Directors
- Matthew Patterson: Elected with 25,310,630 votes for, 670,772 withheld, and 2,788,097 broker non-votes.
- Daniella Beckman: Elected with 25,076,686 votes for, 904,716 withheld, and 2,788,097 broker non-votes.
- Kush M. Parmar, M.D., Ph.D.: Elected with 21,057,872 votes for, 4,923,530 withheld, and 2,788,097 broker non-votes.
- Proposal 2: Ratification of Independent Registered Public Accounting Firm
- Stockholders ratified the selection of Ernst & Young LLP for the fiscal year ending December 31, 2022.
- Votes For: 28,763,851
- Votes Against: 3,220
- Votes Abstain: 2,428
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the tenure of the newly elected directors (Matthew Patterson, Daniella Beckman, and Kush Parmar) through the 2025 Annual Meeting.
- Note the significant number of votes withheld for Kush Parmar (4,923,530) compared to the other nominees.
- Confirm the engagement of Ernst & Young LLP as the independent auditor for the 2022 fiscal year.
- Review the definitive proxy statement on Schedule 14A (filed April 28, 2022) for detailed descriptions of the proposals.